At the NorthShore Kellogg Cancer Center, our highest priority is the health and safety of the communities we serve. We remain open to serve you, either through Telehealth visits (via phone or video) or in-person for active treatment and other critical care needs during your diagnostic and treatment journey. Rest assured that our team has extra safety measures in place should you need to visit any of our facilities for care.
Continuing to provide you with the cancer care you need during the COVID-19 (Coronavirus) pandemic is of the utmost importance to us. Please reach out to your physician via NorthShoreConnect or call 847.570.2112 to discuss the best appointment option for your needs.
For information regarding COVID-19 Vaccine, please read the Vaccine Information for Cancer/Immunocompromised Patients. Additional guidelines are provided and referenced from The American Society of Clinical Oncology (ASCO) and The National Cancer Care Network (NCCN).
Bruce Brockstein, MD, Medical Director, Kellogg Cancer Center, shares a message about cancer care during COVID-19.
Personalized Cancer Treatment | Patient-Centered Cancer Care | Multidisciplinary Oncology Team | Innovative Cancer Research
Personalized Cancer Treatment
At NorthShore Kellogg Cancer Center, our collaborative team of physicians, nurses and other specially trained clinicians are dedicated to providing you with the highest level of customized care. Personalized medicine is no longer just the future of medicine, it is here. Our patients benefit from individualized treatment plans and the most sophisticated genomic and tumor analysis that directs therapy to one’s own “personal” tumor characteristics.
And just as important as DNA, we personalize treatment with a holistic approach, attending not only to your medical but also nutritional, psychological, financial and social needs. Our advanced molecular pathology and diagnostics laboratory capabilities allow us to leverage our considerable strengths in cancer care. Additionally, the continual expansion of our comprehensive immunotherapy program ensures that our patients benefit from leading-edge technology and sophisticated treatment options.
As NorthShore, we have become a national force in the integration of complex genomic information into clinical care. Now, we are establishing a groundbreaking program to incorporate the latest in genomic testing and science for our advanced cancer patients. The Kellogg Cancer Genomic Initiative reflects our commitment to personalized medicine and superior care.
Patient-Centered Cancer Care
Kellogg Cancer Center’s collaborative approach to cancer care goes beyond medical treatment and provides a wide array of support services to patients and their families, including:
NorthShore is certified by the American Society of Clinical Oncology (ASCO) Quality Oncology Practice Initiative (QOPI) as a premier medical provider for practicing the highest standards for quality cancer care. The Commission on Cancer has continuously accredited NorthShore as an Academic Comprehensive Cancer Program since 1981.
We remain committed to advancing efforts to prevent, diagnose and treat even the most complex cancers. We invite you to learn more about our team’s shared mission to provide transformative care.
Multidisciplinary Oncology Team
At the Kellogg Cancer Center, we are truly dedicated to improving patient outcomes. We come together as a team of specialty trained physicians, nurses and healthcare professionals, with the most advanced technology and expertise, all working to provide the best possible care to each individual patient.
Innovative Cancer Research
From the quickly evolving world of immunotherapy, which we have made a priority and conducted a vast array of clinical trials, to surgical enhancements including robotic pancreatic cancer surgery, we ensure that our patients have access to the latest and most effective therapies.
As both a teaching and research-driven program, we set ourselves apart from many other healthcare institutions. Another distinguishing feature is our close partnership with the University of Chicago Pritzker School of Medicine and its science faculty.